MedPath

Cosyntropin

cosyntropin for injection For diagnostic use only

Approved
Approval ID

09441f78-7350-0cb3-e063-6394a90a46ab

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 3, 2023

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cosyntropin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71872-7313
Application NumberANDA202147
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cosyntropin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 3, 2023
FDA Product Classification

INGREDIENTS (2)

MANNITOLInactive
Quantity: 10 mg in 1 mL
Code: 3OWL53L36A
Classification: IACT
COSYNTROPINActive
Quantity: 0.25 mg in 1 mL
Code: 72YY86EA29
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.